At least 83% of U.S. patient advocacy organizations receive financial support from medical device, drug and biotechnology companies, according to new research out of the University of Pennsylvania’s Department of Medical Ethics and Health Policy. The Penn research team – which included Matthew McCoy, Harald Schmidt and Ezekiel Emanuel – examined websites and annual reports for 104 organizations […]
Patient Monitoring
GlucoMe tackles connected diabetes management with acoustic data transmission
The Centers for Disease Control & Prevention predict that by 2050, if current trends continue, 1 in 3 adults in the U.S. will have diabetes. The digital diabetes management company GlucoMe hopes it can develop a smarter healthcare model t0 fit this growing patient population. “Diabetes is an inter-world epidemic – a pandemic – and the number of […]
Cohero Health oversubscribes Series A for connected respiratory tech
Cohero Health said today that it oversubscribed its $9 million Series A round with investments from Samsung Next and Omron Healthcare The latest contributions will be used to support commercialization of hardware and software for its BreatheSmart connected respiratory disease management platform, the N.Y.-based company said. “BreatheSmart from Cohero Health provides both connected hardware and software as […]
Sanofi, Voluntis ink deal for digital insulin management system for T2D
Sanofi (NYSE:SNY) and Voluntis said today that the groups inked a non-exclusive agreement to bring digital insulin management systems for Type II diabetes to the U.S. and several European countries. The companies 1st established in alliance in 2011, developing a mobile phone application that was designed to improve decision-making and self-management of patients with Type II […]
Virta Health looks to reverse, not treat, Type II diabetes
Virta Health, founded by physicians and scientists from Stanford, MIT and Harvard, launched today with the goal to reverse Type II diabetes using its technology platform to enable personalized remote care. The company provides physician supervision, health coaches, an app and biomarker tracking tools, as well as a personalized nutrition plan for its patients in […]
Common Sensing, Welkin Health collaborate on digital diabetes management system
Common Sensing and Welkin Health said last month that the companies are partnering to develop a digital diabetes management program designed to improve insulin adherence. The companies plan to craft a program that combines insulin dosing data collected from Common Sensing’s Gocap smart insulin pen with Welkin Health’s digital coaches to support patients with diabetes. […]
QuiO adds MedCrypt data security to Smartinjector pen
MedCrypt and QuiO said earlier this month that the companies are partnering to integrate MedCrypt’s data security software into QuiO’s Smartinjector devices. According to the agreement, MedCrypt will provide software security for QuiO’s Si One pen for specialty drugs and the Si Pen for diabetes patients. The companies plan to integrate the devices with software […]
Abbott touts association between monitoring and improved glucose control
Abbott (NYSE:ABT) touted results today from real-world use data for its FreeStyle Libre blood glucose monitoring system. The data showed that people using its FreeStyle Libre system to monitor their glucose levels spend less time in hypoglycemia or hyperglycemia and have improved average glucose levels. More than 50,000 diabetes patients using the FreeStyle Libre system checked […]
Cohero raises $13.3m for connected inhaler tech
Cohero Health said today that it raised more than $13.3 million, according to regulatory filings, in equity and Series A preferred stock. The company sold nearly all of its total offering amount of $13.6 million before closing the round. Over 50 investors have contributed to the offering, which had its 1st sale in October last year. […]
Sunovion launches clinical trial for anti-epileptic drug with wearable tech
Sunovion Pharmaceuticals said today that it will soon begin enrollment for a Phase IV study of its anti-epileptic drug Aptiom with Empatica‘s Embrace watch. The Marlborough, Mass.-based company touted its study as the 1st to incorporate a wearable seizure device with an anti-epileptic drug into the design of a clinical trial for partial-onset seizures. The Embrace watch […]